Filter
1077
Filtered Results: 1077
Text search:
Tromp,
J.
Featured
Recommendations
86
New Publications
221
Language
Document type
No document type
529
Studies & Reports
310
Guidelines
117
Manuals
44
Fact sheets
28
Strategic & Response Plan
23
Training Material
16
Situation Updates
6
Infographics
3
Resource Platforms
1
Countries / Regions
Global
46
Latin America and the Carribbean
32
Africa
27
Burkina Faso
24
Senegal
24
Uganda
21
Congo, Democratic Republic of
18
India
18
Malawi
17
South Africa
16
Sierra Leone
15
Cameroon
15
Benin
15
Ethiopia
14
Mozambique
13
West and Central Africa
13
Western and Central Europe
13
Guinea
12
Venezuela
12
Kenya
11
Brazil
11
Liberia
10
Syria
10
Tanzania
10
Russia
10
Haiti
9
Rwanda
8
Colombia
8
Myanmar / Burma
8
Asia
8
Nigeria
7
Mali
7
Ukraine
7
East and Southern Africa
7
Philippines
6
Argentina
6
Nepal
5
South Sudan
5
Zambia
5
Bangladesh
5
Eastern Europe
5
Zimbabwe
4
Germany
4
Central African Republic
4
Angola
4
Yemen
4
Côte d’Ivoire / Ivory Coast
3
Ghana
3
Somalia
3
Chad
3
Ecuador
3
Madagascar
3
Lesotho
3
Middle East and North Africa
3
Paraguay
3
North America
3
Guinea-Bissau
2
Iraq
2
Jordan
2
Lebanon
2
Thailand
2
Sudan
2
Bolivia
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Southern Africa
2
France
2
Morocco
1
USA
1
Saudi Arabia
1
Togo
1
Pakistan
1
Afghanistan
1
Turkey
1
Egypt
1
Cambodia
1
Indonesia
1
Papua New Guinea
1
Dominican Republic
1
Namibia
1
Peru
1
Botswana
1
Libya
1
Western Pacific Region
1
Palestine
1
Italy
1
Djibouti
1
Qatar
1
Iran
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
304
Clinical Guidelines
146
Women & Child Health
57
Public Health
53
Key Resources
28
Pharmacy & Technologies
14
Capacity Building
12
Toolboxes
NTDs
117
HIV
87
TB
85
COVID-19
77
Mental Health
61
Planetary Health
48
Ebola
39
Rapid Response
39
Zika
26
AMR
26
Caregiver
26
Disability
19
Global Health Education
15
Health Financing Toolbox
13
NCDs
12
Cholera
11
Conflict
11
Refugee
11
Pharmacy
11
Polio
6
Specific Hazards
3
Social Ethics
3
Natural Hazards
2
El presente documento reúne un conjunto de recomendaciones formuladas por la Organización Mundial de la Salud (OMS) y la Organización Panamericana de la Salud (OPS) para ayudar, a los profesionales encargados de los programas de control de vectores de Latinoamérica y el Caribe a nivel nacional, ...
Le présent document rassemble une série de recommandations émises par l’Organisation mondiale de la Santé (OMS) et l’Organisation panaméricaine de la Santé (OPS) pour aider les professionnels chargés des programmes de lutte antivectorielle en Amérique latine et dans les Caraïbes aux niv...
Este documento reúne um conjunto de recomendações formuladas pela OMS e pela OPAS para ajudar os profissionais responsáveis pelos programas de controle de vetores nas Américas em nível nacional, subnacional e local a se atualizarem e tomarem decisões baseadas em evidências sobre as medidas d...
Epidemiology
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or...
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or drink.1-4 The...
Revised and expanded version of the Guidelines
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the ...
Chagas disease (CD) is endemic in the Americas, being present in 21 countries, where it affects about 6 million
people.(1) With such relevant numbers of people affected and disability adjusted life years lost, CD is a poverty-related
and poverty-promoting disease.
Although data describe a relevan...
Theodor Bilharz, a German professor of anatomy and chief of surgery at the Kasr El Ani Hospital of Cairo from 1850, first identified an infective organism, Distomum hematobium in 1851, which was renamed Schistosoma haematobium in 1858. It arose from a cestode worm, Hymenoleptis nana, lying in the sm...
Schistosoma haematobium is a parasitic digenetic trematode responsible for schistosomiasis (also known as bilharzia). The disease is caused by penetration of the skin by the parasite, spread by intermediate host molluscs in stagnant waters, and can be treated by administration of praziquantel. Schis...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani...
Cholera which disproportionally impacts poor countries and the most vulnerable continues to affect at least 47 countries across the globe, resulting in an estimated 1.3 – 4 million cases, and 21,000 - 143,000 deaths per year worldwide. In Ethiopia, despite major improvements seen in the increasing...
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies of haemoflagellate parasite, Trypanosoma brucei and transmitted by tsetse flies. Progress made in HAT ...
Gambiense human African trypanosomiasis is a deadly infectious disease affecting West and Central Africa, South Sudan and Uganda, and transmitted between humans by tsetse flies. The disease has caused several major epidemics, the latest one in the 1990s. Thanks to recent innovations such as rapid di...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
Yaws is a disfiguring non-venereal disease caused by infection with the spirochaete. Treponema pallidum subspecies pertenue which is closely related to the causative agent of syphilis and those of the other endemic treponematoses, bejel and pinta. The disease is endemic in certain areas of the World...
Onchocerciasis used to be an important public health problem in Africa, with over 37 million people infected and millions suffering from debilitating skin disease, terrible itching, impaired vision and
blindness. But the epidemiological situation has improved dramatically over the last two decades....
Mali national action plan on antimicrobial resistance: review of progress in the human health sector
This policy brief aims to provide a review of the current progress on implementing the Mali national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing act...
Les directives 2021 de l’European Resuscitation Council (ERC - Conseil Européen de Réanimation) sont fondées sur une série de revues systématiques, sur la revue du champ d'application, et sur les mises à jour des évidences de sciences de l’ILCOR (International Liaison Commitee on Resuscit...
